节点文献

高纯度胰岛素的研制与临床试用

The Preparation or Highly Purified Insulin and Its Clinical Use

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 杨继虞; 方芳; 祝小元; 邓尚平; 周文碧; 熊中云;

【Author】 Yang Jiyu;Fong Fang;Zhu Xiaoyuan;Deng Shangpin;Zhou Wenbi;Xing Zhongyun Department of Biochemistry,School of Pharmacy Clincal Immunological Centre Insulin Cooperative Study Group

【机构】 药学院生物化学教研室; 华西医大临床免疫中心; 华西医大临床免疫中心;

【摘要】 胰岛素制剂的免疫原性与其纯度密切相关。作者研制的高纯度胰岛素(HP-I)其主要大分子杂质胰岛素原、胰高血糖素和胰多肽的含量分别为76.00、2.11和0.11ppm。产品的纯度显著优于国产普通结晶胰岛素,并超过国外单峰胰岛素(SP-I)的质量标准。临床试用结果,病人血清中胰岛素、胰岛素原和胰多肽等三种特异抗体的阳性率分别为37.5%、0%和0%。其免疫原性也明显低于国产普通结晶胰岛素、接近丹麦单组分胰岛素(MC-I,Nordisk)的水平。

【Abstract】 Antigenicity of insulinpreparations is obviously related to theirpurity. The average contents of proinsu-lin. glucagon and pancreatic polypeptidein highly purified insulin (HP-I) producedby us are 76.0, 2.11 and 0.11 ppm respec-tively. These results are superior to thosefor domestic conventional crystalline insu-lin and single peak insulin (SP-I). The antibodies to insulin, proinsulinand pancreatic polypeptide in erum wereexamined in 24 diabetic patients treatedwith HP-I for more than 6 months. Thepositive rates for the above three antibod-ies were 37.5%, 0% and 0% respectively.the results showed that the antigenicityof HP-I was much lower than that of do-mestic conventional crystalline insulin andalmost the same as that of MC-I fromNordisk, Denmark.

【基金】 卫生部及商业部资助课题
  • 【被引频次】8
  • 【下载频次】52
节点文献中: 

本文链接的文献网络图示:

本文的引文网络